| Chapter title |
Familial amyloidotic polyneuropathy and transthyretin.
|
|---|---|
| Chapter number | 21 |
| Book title |
Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease
|
| Published in |
Sub cellular biochemistry, December 2012
|
| DOI | 10.1007/978-94-007-5416-4_21 |
| Pubmed ID | |
| Book ISBNs |
978-9-40-075415-7, 978-9-40-075416-4
|
| Authors |
Nagasaka T, Takamura Nagasaka, Nagasaka, Takamura |
| Abstract |
There has been much progress in our understanding of transthyretin (TTR)-related amyloidosis including familial amyloidotic polyneuropathy (FAP), senile systemic amyloidosis and its related disorders from many clinical and experimental aspects. FAP is an inherited severe systemic amyloidosis caused by mutated TTR, and characterized by amyloid deposition mainly in the peripheral nervous system and the heart. Liver transplantation is the only available treatment for the disease. FAP is now recognized not to be a rare disease, and to have many variations based on genetical and biochemical variations of TTR. This chapter covers the recent advances in the clinical and pathological aspects of, and therapeutic approaches to FAP, and the trend as to the molecular pathogenesis of TTR. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| United Kingdom | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | 6% |
| Unknown | 15 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 31% |
| Student > Bachelor | 2 | 13% |
| Student > Postgraduate | 2 | 13% |
| Professor | 1 | 6% |
| Student > Ph. D. Student | 1 | 6% |
| Other | 1 | 6% |
| Unknown | 4 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 4 | 25% |
| Agricultural and Biological Sciences | 2 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 6% |
| Biochemistry, Genetics and Molecular Biology | 1 | 6% |
| Economics, Econometrics and Finance | 1 | 6% |
| Other | 3 | 19% |
| Unknown | 4 | 25% |